Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Triggered trap": nevoid malignant melanoma

N S McNutt1

  • 1Department of Pathology, New York Hospital-Cornell University Medical Center, NY 10022, USA.

Seminars in Diagnostic Pathology
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histopathological characteristics of small diameter melanocytic naevi.

Journal of clinical pathology·2003
Same author

Bone lesions and facial papules in a 41-year-old female.

Journal of cutaneous medicine and surgery·2002
Same author

S100A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for Schwannian differentiation of intradermal nevi.

Journal of cutaneous pathology·2001
Same author

S100A6 expression in fibrohistiocytic lesions.

Journal of cutaneous pathology·2001
Same author

Lichen striatus. Histological, immunohistochemical, and ultrastructural study of 37 cases.

Journal of cutaneous pathology·2001
Same author

Photo quiz. Fibrous histiocytoma.

Cutis·2000
Same journal

Update on the molecular pathology of the distinctive giant cell, fibro-osseous and bone forming lesions of the jaws.

Seminars in diagnostic pathology·2026
Same journal

Update on the molecular pathology and classification of odontogenic cysts and tumours.

Seminars in diagnostic pathology·2026
Same journal

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026
Same journal

When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses.

Seminars in diagnostic pathology·2026
Same journal

Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.

Seminars in diagnostic pathology·2026
Same journal

Recent advances in genetic predisposition to primary testicular tumors.

Seminars in diagnostic pathology·2026
See all related articles

Nevoid malignant melanoma, an early nodular melanoma, presents diagnostic challenges due to its benign-like dermal proliferation. Immunohistochemistry markers like HMB-45 and Ki-67 aid in identifying immature dermal cells for accurate diagnosis.

Area of Science:

  • Dermatopathology
  • Oncology
  • Melanoma Research

Background:

  • Nevoid malignant melanoma (NMM) is a challenging subtype of melanoma.
  • It often mimics benign nevi due to minimal epidermal melanocyte proliferation and dermal growth.
  • Distinguishing NMM from common melanocytic nevi is crucial for patient prognosis.

Observation:

  • NMM lesions exhibit symmetry and minimal epidermal melanocyte proliferation.
  • Dermal proliferation in NMM can resemble features of compound or intradermal nevi.
  • Lesions may contain small nevoid cells or larger cells similar to Spitz nevi.

Findings:

  • Lesions with small nevoid cells are particularly difficult to differentiate from benign nevi.
  • Immunohistochemical staining for HMB-45 (without antigen retrieval) and Ki-67 can reveal immature dermal cell phenotypes.

Related Experiment Videos

  • These immunohistochemical findings, alongside histological criteria, support the diagnosis of NMM.
  • Implications:

    • Accurate diagnosis of NMM is vital for appropriate treatment and improved patient outcomes.
    • The use of specific immunohistochemical markers can enhance diagnostic accuracy.
    • Further research into NMM's pathogenesis may reveal novel therapeutic targets.